Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2020; 10(Volume 10, Issue 4.000): 100-112


Formulation and stability studies of Metformin Hydrochloride in a controlled porosity osmotic pump system

Hanan M. Hashem, Aya R. Abdou, Nesrin F. Taha, Nadia M. Mursi, Laila H. Emara.




Abstract
Cited by 3 Articles

This study was designed to formulate, for the first time, Metformin Hydrochloride (MH, 850 mg/tablet) as a controlled porosity osmotic pump (CPOP) system to achieve zero-order release pattern. MH core tablet was coated with cellulose acetate membrane containing PEG 400. The effect of different percentages and molecular weights (900K and 4M) of Polyethylene oxide (PEO, 900K and 4M) in tablet core was studied. The release studies were done in phosphate buffer pH 6.8 using USP apparatus II and phosphate buffer pH 6.8 were used for the release studies, meanwhile a promising formula was tested in biorelevant media. Stability of some selected formulationse was carried-out for 6 months, at bench and accelerated conditions. Evaluation included: MH content, DSC, SEM, drug release and kinetics. Results revealed that increasing PEO percentage within the core drove to decreased MH release. SEM confirmedverified formation of pores in the membrane that accounts for MH release. Almost all stored tablets were stable for all studied parameters. MH endothermic peak maintained its position and energy of enthalpy upon storage as confirmed by DSC. MH release rate from a promising formula, following zero-order release model, increased by 28% in biorelevant media compared to phosphate buffer. Subsequently, in vitro release in biorelevant media could be employed as a tool to anticipate in vivo tone of CPOP formulationse.

Key words: Controlled porosity osmotic pump, Metformin Hydrochloride, Biorelevant media, FaSSGF, FaSSIF, Stability studies.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.